BioCentury
ARTICLE | Clinical News

Monoclonal antibodies against PSMA regulatory update

August 28, 2000 7:00 AM UTC

Cornell University received U.S. patent No. 6,107,090 covering the use of monoclonal antibodies that bind to the extracellular domain of prostate-specific membrane antigen (PSMA), to treat or diagnos...